Actively Recruiting
Influence of the Glycemic and Ponderal Status on Tissues Gene Expression Biological Tissue Collection for Obesity and Diabetes
Led by University Hospital, Lille · Updated on 2025-12-08
20000
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are investigating the relationship between obesity and type 2 diabetes, conditions influenced by both genetic and environmental factors. This study aims to better understand how different genetic variations affect gene expression in tissues involved in glucose and lipid metabolism, which may contribute to what is called diabesity, a combined condition of diabetes and obesity. The study uses advanced genomic techniques and bioinformatics to analyze these factors in both humans and animal models. Participants in this observational study are grouped based on their body mass index BMI and diabetes or glucose intolerance status. Groups include individuals with BMI 35 kgm2 with diabetes, glucose intolerance, or without diabetes, as well as those with BMI 27 kgm2 and BMI between 27 and 35 kgm2 without diabetes. Samples are collected during abdominal surgeries such as bariatric surgery or cholecystectomy to study gene expression and metabolic pathways. During the study, researchers collect biological samples at baseline and follow participants over several years to assess changes in gene expression and insulin resistance. They also evaluate clinical and biological features before and after bariatric surgery at 1, 2, and 5 years. The primary measurement focuses on gene expression in tissues related to glucose metabolism. This long-term observation helps to understand the genetic and phenotypic factors influencing obesity and diabetes, with participation lasting up to 5 years.
CONDITIONS
Brief Title
A Biological Atlas of Severe Obesity (Biological Tissue Collection)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age between 18 and 65 years
- Scheduled for abdominal surgery requiring laparotomy or laparoscopy such as bariatric surgery, gallbladder removal, or abdominal wall surgery
- Body Mass Index (BMI) ≥ 35 kg/m2 with diabetes (fasting blood glucose ≥ 7 mmol/l and/or ≥ 11.1 mmol/l after 120 minutes of glucose ingestion)
- Body Mass Index (BMI) ≥ 35 kg/m2 with glucose intolerance (fasting blood glucose > 6 mmol/L and < 7 mmol/l and/or > 7.8 mmol/l and < 11.1 mmol/l after 120 minutes of glucose ingestion)
- Body Mass Index (BMI) ≥ 35 kg/m2 without diabetes (blood glucose ≤ 6 mmol/L and/or ≤ 7.8 mmol/l after 120 minutes of glucose ingestion)
- Body Mass Index (BMI) < 27 kg/m2 without diabetes (blood glucose ≤ 6 mmol/L and/or ≤ 7.8 mmol/l after 120 minutes of glucose ingestion)
- Body Mass Index (BMI) between 27 and 35 kg/m2 without diabetes (blood glucose ≤ 6 mmol/L and/or ≤ 7.8 mmol/l after 120 minutes of glucose ingestion)
You will not qualify if you...
- Unable to receive clear information about the study
- Refusal to sign the consent form
- Any pathology judged by the surgeon to increase risk of adverse events related to tissue sampling
Research Team
F
Francois PATTOU, MD PhD
V
Violeta Raverdy, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here